rs41276710

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000719.7(CACNA1C):​c.4485T>C​(p.Asp1495Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00979 in 1,613,432 control chromosomes in the GnomAD database, including 701 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.039 ( 350 hom., cov: 32)
Exomes 𝑓: 0.0067 ( 351 hom. )

Consequence

CACNA1C
NM_000719.7 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.470

Publications

4 publications found
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
CACNA1C Gene-Disease associations (from GenCC):
  • Timothy syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • long QT syndrome
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • long QT syndrome 8
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • Brugada syndrome
    Inheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: Orphanet, ClinGen
  • Brugada syndrome 3
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • short QT syndrome
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 12-2665667-T-C is Benign according to our data. Variant chr12-2665667-T-C is described in ClinVar as Benign. ClinVar VariationId is 93407.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.47 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.126 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1CNM_000719.7 linkc.4485T>C p.Asp1495Asp synonymous_variant Exon 36 of 47 ENST00000399655.6 NP_000710.5
CACNA1CNM_001167623.2 linkc.4485T>C p.Asp1495Asp synonymous_variant Exon 36 of 47 ENST00000399603.6 NP_001161095.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1CENST00000399603.6 linkc.4485T>C p.Asp1495Asp synonymous_variant Exon 36 of 47 5 NM_001167623.2 ENSP00000382512.1
CACNA1CENST00000399655.6 linkc.4485T>C p.Asp1495Asp synonymous_variant Exon 36 of 47 1 NM_000719.7 ENSP00000382563.1
CACNA1CENST00000682544.1 linkc.4719T>C p.Asp1573Asp synonymous_variant Exon 38 of 50 ENSP00000507184.1
CACNA1CENST00000406454.8 linkc.4485T>C p.Asp1495Asp synonymous_variant Exon 36 of 48 5 ENSP00000385896.3
CACNA1CENST00000399634.6 linkc.4452T>C p.Asp1484Asp synonymous_variant Exon 35 of 47 5 ENSP00000382542.2
CACNA1CENST00000683824.1 linkc.4650T>C p.Asp1550Asp synonymous_variant Exon 37 of 48 ENSP00000507867.1
CACNA1CENST00000347598.9 linkc.4629T>C p.Asp1543Asp synonymous_variant Exon 38 of 49 1 ENSP00000266376.6
CACNA1CENST00000344100.7 linkc.4551T>C p.Asp1517Asp synonymous_variant Exon 36 of 47 1 ENSP00000341092.3
CACNA1CENST00000327702.12 linkc.4485T>C p.Asp1495Asp synonymous_variant Exon 36 of 48 1 ENSP00000329877.7
CACNA1CENST00000399617.6 linkc.4485T>C p.Asp1495Asp synonymous_variant Exon 36 of 48 5 ENSP00000382526.1
CACNA1CENST00000682462.1 linkc.4575T>C p.Asp1525Asp synonymous_variant Exon 36 of 47 ENSP00000507105.1
CACNA1CENST00000683781.1 linkc.4575T>C p.Asp1525Asp synonymous_variant Exon 36 of 47 ENSP00000507434.1
CACNA1CENST00000683840.1 linkc.4575T>C p.Asp1525Asp synonymous_variant Exon 36 of 47 ENSP00000507612.1
CACNA1CENST00000683956.1 linkc.4575T>C p.Asp1525Asp synonymous_variant Exon 36 of 47 ENSP00000506882.1
CACNA1CENST00000399638.5 linkc.4569T>C p.Asp1523Asp synonymous_variant Exon 37 of 48 1 ENSP00000382547.1
CACNA1CENST00000335762.10 linkc.4560T>C p.Asp1520Asp synonymous_variant Exon 37 of 48 5 ENSP00000336982.5
CACNA1CENST00000399606.5 linkc.4545T>C p.Asp1515Asp synonymous_variant Exon 37 of 48 1 ENSP00000382515.1
CACNA1CENST00000399621.5 linkc.4485T>C p.Asp1495Asp synonymous_variant Exon 36 of 47 1 ENSP00000382530.1
CACNA1CENST00000399637.5 linkc.4485T>C p.Asp1495Asp synonymous_variant Exon 36 of 47 1 ENSP00000382546.1
CACNA1CENST00000402845.7 linkc.4485T>C p.Asp1495Asp synonymous_variant Exon 36 of 47 1 ENSP00000385724.3
CACNA1CENST00000399629.5 linkc.4536T>C p.Asp1512Asp synonymous_variant Exon 36 of 47 1 ENSP00000382537.1
CACNA1CENST00000682336.1 linkc.4527T>C p.Asp1509Asp synonymous_variant Exon 36 of 47 ENSP00000507898.1
CACNA1CENST00000399591.5 linkc.4452T>C p.Asp1484Asp synonymous_variant Exon 35 of 46 1 ENSP00000382500.1
CACNA1CENST00000399595.5 linkc.4452T>C p.Asp1484Asp synonymous_variant Exon 35 of 46 1 ENSP00000382504.1
CACNA1CENST00000399649.5 linkc.4446T>C p.Asp1482Asp synonymous_variant Exon 35 of 46 1 ENSP00000382557.1
CACNA1CENST00000399597.5 linkc.4485T>C p.Asp1495Asp synonymous_variant Exon 36 of 47 1 ENSP00000382506.1
CACNA1CENST00000399601.5 linkc.4485T>C p.Asp1495Asp synonymous_variant Exon 36 of 47 1 ENSP00000382510.1
CACNA1CENST00000399641.6 linkc.4485T>C p.Asp1495Asp synonymous_variant Exon 36 of 47 1 ENSP00000382549.1
CACNA1CENST00000399644.5 linkc.4485T>C p.Asp1495Asp synonymous_variant Exon 36 of 47 1 ENSP00000382552.1
CACNA1CENST00000682835.1 linkc.4485T>C p.Asp1495Asp synonymous_variant Exon 36 of 47 ENSP00000507282.1
CACNA1CENST00000683482.1 linkc.4476T>C p.Asp1492Asp synonymous_variant Exon 36 of 47 ENSP00000507169.1
CACNA1CENST00000682686.1 linkc.4452T>C p.Asp1484Asp synonymous_variant Exon 35 of 46 ENSP00000507309.1

Frequencies

GnomAD3 genomes
AF:
0.0390
AC:
5938
AN:
152092
Hom.:
348
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.129
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0149
Gnomad ASJ
AF:
0.00230
Gnomad EAS
AF:
0.000579
Gnomad SAS
AF:
0.0102
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.00348
Gnomad OTH
AF:
0.0292
GnomAD2 exomes
AF:
0.0122
AC:
3039
AN:
249384
AF XY:
0.0102
show subpopulations
Gnomad AFR exome
AF:
0.135
Gnomad AMR exome
AF:
0.00858
Gnomad ASJ exome
AF:
0.00159
Gnomad EAS exome
AF:
0.000442
Gnomad FIN exome
AF:
0.0000928
Gnomad NFE exome
AF:
0.00319
Gnomad OTH exome
AF:
0.00595
GnomAD4 exome
AF:
0.00673
AC:
9839
AN:
1461222
Hom.:
351
Cov.:
31
AF XY:
0.00652
AC XY:
4739
AN XY:
726914
show subpopulations
African (AFR)
AF:
0.141
AC:
4730
AN:
33466
American (AMR)
AF:
0.00897
AC:
401
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.00149
AC:
39
AN:
26122
East Asian (EAS)
AF:
0.000252
AC:
10
AN:
39690
South Asian (SAS)
AF:
0.00820
AC:
707
AN:
86246
European-Finnish (FIN)
AF:
0.000206
AC:
11
AN:
53376
Middle Eastern (MID)
AF:
0.0141
AC:
81
AN:
5762
European-Non Finnish (NFE)
AF:
0.00284
AC:
3162
AN:
1111504
Other (OTH)
AF:
0.0116
AC:
698
AN:
60346
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
420
839
1259
1678
2098
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
216
432
648
864
1080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0391
AC:
5953
AN:
152210
Hom.:
350
Cov.:
32
AF XY:
0.0378
AC XY:
2813
AN XY:
74432
show subpopulations
African (AFR)
AF:
0.129
AC:
5364
AN:
41514
American (AMR)
AF:
0.0148
AC:
227
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00230
AC:
8
AN:
3472
East Asian (EAS)
AF:
0.000580
AC:
3
AN:
5168
South Asian (SAS)
AF:
0.00996
AC:
48
AN:
4820
European-Finnish (FIN)
AF:
0.000188
AC:
2
AN:
10616
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.00348
AC:
237
AN:
68008
Other (OTH)
AF:
0.0289
AC:
61
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
270
540
810
1080
1350
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
62
124
186
248
310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0181
Hom.:
123
Bravo
AF:
0.0445
Asia WGS
AF:
0.0110
AC:
39
AN:
3478
EpiCase
AF:
0.00360
EpiControl
AF:
0.00445

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Apr 09, 2025
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 23, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Long QT syndrome Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Jun 26, 2015
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.48
CADD
Benign
6.2
DANN
Benign
0.84
PhyloP100
0.47
Mutation Taster
=93/7
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41276710; hg19: chr12-2774833; API